Regulatory updates regarding cannabis-derived products are happening quickly, making it difficult for businesses to predict what’s ahead. Is the CBD market likely to continue its explosive growth? Will increased research lead to more FDA-approved THC- and CBD-containing drugs? Will legalization of state medical/adult-use marijuana continue to spread? With more than half of Americans supporting marijuana legalization in some form, how probable is federal legalization? What would marijuana legalization at the federal level look like? Is Congress likely to enact banking protections for cannabis businesses? This session will discuss the future of federal and state regulation. We will also cover whether legalization in other countries, such as Canada, is likely to impact U.S. policies.
Linda D. Bentley, Member, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Kelly Fair, Director of Legal, USA, Canopy Growth Corporation
Andrew Kline, Director of Public Policy, National Cannabis Industry Association
Moderated by Michael Werner, Partner, Holland & Knight LLP